NCT07120945 2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA Recruiting
Clinical Trials
29 trialsNCT07144345 2026-03-05
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Sun Pharmaceutical Industries Limited
Phase 3 Active not recruiting
NCT07144852 2026-02-20
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Sun Pharmaceutical Industries Limited
Phase 3 Active not recruiting
NCT06135415 2026-01-22
TirbAKare
Almirall, S.A.
Phase 3 Completed
NCT05407311 2025-11-17
SABRE
Clarity Pharmaceuticals Ltd
Phase 2 Completed
NCT02158858 2025-10-08
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Phase 1/2 Completed
NCT05934331 2025-09-12
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
LaNova Medicines Limited
Phase 2 Recruiting
NCT05997342 2025-08-11
A Clinical Study of TQB3912 Tablets in Patients With Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT06344351 2025-05-22
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
NCT05060237 2024-10-17
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Biofrontera Bioscience GmbH
Phase 1 Completed
NCT05249127 2024-10-01
COBRA
Clarity Pharmaceuticals Ltd
Phase 1/2 Completed
NCT06297642 2024-08-06
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Terminated
NCT06165809 2023-12-29
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Withdrawn
NCT02121873 2023-07-20
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Atossa Therapeutics, Inc.
Completed
NCT05867563 2023-07-10
Clinical Trial Evaluating the Safety of the TQB2103 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT00106691 2023-06-12
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
GTx
Phase 3 Completed
NCT02844777 2023-01-12
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Vidac Pharma
Phase 2 Completed
NCT03088527 2022-08-18
Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast Cancer
Stemline Therapeutics, Inc.
Phase 1 Completed
NCT05048160 2022-05-09
A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT03051035 2021-09-20
First-in-Human Study of KO-947 in Non-Hematological Malignancies
Kura Oncology, Inc.
Phase 1 Terminated
NCT03285477 2021-04-13
AK003
Almirall, S.A.
Phase 3 Completed
NCT00128661 2019-03-08
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
GlaxoSmithKline
Phase 3 Completed
NCT03266042 2018-09-11
Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy
Delcath Systems Inc.
Unknown
NCT01752114 2018-03-01
Early Diagnosis of Pulmonary Nodules
Integrated Diagnostics
Completed
NCT02539615 2016-01-25
A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old
Atossa Therapeutics, Inc.
Phase 3 Withdrawn
NCT01752101 2015-01-09
Identification of a Plasma Proteomic Signature for Lung Cancer
Integrated Diagnostics
Completed
NCT01117246 2012-02-20
Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFU
Philips Healthcare
Phase 1/2 Completed
NCT00692159 2010-09-10
Study of TRC102 in Combination With Pemetrexed in Cancer Patients
Tracon Pharmaceuticals Inc.
Phase 1 Completed
NCT00036283 2008-09-29
Chemoprevention of Oral Premalignant Lesions
Pfizer
Phase 2 Completed